Is it just ADHD? Broadening the scope of ADHD diagnosis and treatment
With over 12 years’ experience as a paediatric/neonatal doctor in the NHS working in paediatric units, including neonatal intensive care units, Dr Datt has a specialist interest in neurology, rare paediatric diseases, and developmental clinics, with associated mental health disorders including Autism Spectrum Disorder (ASD), and Attention Deficit Hyperactivity Disorder (ADHD).
Dr Datt’s research interests include rare paediatric diseases such as Mucopolysaccharidoses (MPS), Paediatric Multiple Sclerosis, Haemophilia, Sickle Cell Anaemia, Beta-thalassaemia, X-Linked Hypophosphatemia (XLH), Vitamin D deficiency, Achondroplasia, Primary Immunodeficiencies (PID’s), and oncology (especially Astrocytoma and Neuroblastoma) in both small molecule therapeutics, biologics, and gene therapy.
As a postgraduate tutor and board of examiner with the Faculty of Pharmaceutical Medicine (FPM), Dr Datt is a revalidation appraiser on behalf of the Royal College of Physicians for FPM. His passion for delivering optimum client-focused care, extends as he continues to teach junior doctors, delivering medical education and raising awareness of rare paediatric conditions.
After completing a degree in Biological Medicinal Chemistry with Drug Design (BSc.), Dr Datt acquired a postgraduate diploma in Pharmaceutical Medicine from Oxford and graduated from Medical School (MBBS) from the University of East Anglia. He has also undertaken postgraduate certificates and diplomas in child health as well as conducting research in gastro-oesophageal reflux disease and leukaemia at the National Institute for Health (NIH) in Maryland, USA.
What will the webinar cover?
Key learning objectives
- To outline the challenges of ADHD diagnosis and treatment.